Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
The Food and Drug Administration has suggested removing the active ingredients found in popular obesity and diabetes medications…
Hims & Hers made a controversial decision to stop selling a compounded version of Novo Nordisk’s obesity pill…
The ongoing debate surrounding the use of compounded weight loss drugs as a more affordable alternative to branded…
Sign in to your account